ANABIOTICAWhat changed, and why.
Substantive library and source changes are recorded here, newest first. Routine audits with no published change stay in the private audit log.
Added Astaxanthin with an Emerging rating, skin and metabolic evidence, null findings, and safety cautions.
AstaxanthinAdds a distinct oral carotenoid supplement not previously covered in the library, separating preliminary skin and biomarker findings from unproven disease-prevention and longevity claims.
- Skin-ageing systematic review and meta-analysis (2021)
- Skin-health clinical systematic review (2021)
- Randomized UV-response trial (2018)
- Prediabetes and dyslipidaemia randomized trial (2023)
- Prediabetes and type 2 diabetes meta-analysis (2026)
- EFSA supplement safety assessment (2020)
- EFSA assessment of additional food uses (2025)
- Suspected warfarin interaction case report (2019)
Added transparent maintenance and audit practices.
Editorial methodologyReaders should be able to distinguish automated link monitoring from substantive evidence review and see when published content changes.